Combined synopsis and solicitation
1st Tier NBS IS
75D30125Q78685
Centers for Disease Control and Prevention, CDC Office of Acquisition Services. In-Vitro Diagnostic Substance Manufacturing.
Awarded
Cambridge Isotope Laboratories, Inc.
$221,095.00 obligated so far on USAspending
Get the next one like this from Centers for Disease Control and Prevention by email, the day it is posted.Find my opportunities
This one was awarded in 2025
13 like it are open now in in-vitro diagnostic substance manufacturing
- NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes tomorrowNov 2 - HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325413Anywhere in the US36C26227Q0046Closes tomorrowNov 2 - DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325413Anywhere in the US36C77027Q0015Closes in 2 daysNov 3
Description
As published on SAM.gov.
Salient Characteristics: The requirement is for 5 1st Tier Newborn Screening Internal Standard Kits. The kit is a mixture of internal standards for accurate quantification of first-tier newborn screening analytes by mass spectrometry analysis methods. Each kit shall contain 10 vials of the internal standard mixture described in below. The kits shall be delivered within 4 months of the award of the resulting contract.
First-tier newborn screening internal standard kits: The commercial product requested shall be a lyophilized mixture of the concentrated isotopically labeled internal standards with a chemical purity ? 97%, unless otherwise stated below, in a single vial that can be resuspended and transferred. The commercial product shall have a specific storage condition (e.g., 4-10 ?C, -20 ?C) with an expiration date for the commercial product lot being purchased.
The minimum period of stability within the specified storage conditions shall be at least 6 months. These isotopically labeled internal standards present in the commercial product shall have identical isotopic labels and isotopic purities, and final ?M concentration of each internal standard when resuspended in 1 mL of solvent: see solicitation for further details.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Cambridge Isotope Laboratories, Inc.
- UEI
- JNBGUL51AVL8
- CAGE
- 5Y748
- Vendor location
- Andover, MA
- Contract
- 75D30125P20580, purchase order
- Obligated
- $221,095.00
- Actions
- 1 between September 23, 2025 and September 23, 2025
- Competition
- Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- 1ST Tier Newborn Screening Kits
- Match
- solicitation number 75D30125Q78685 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 29, 2025
Combined synopsis and solicitation
Due September 5, 2025 at 2:00 PM EDT. SAM.gov, notice 2d8a67425450472489545d71cbcd425b
Points of contact
- Staci Boykinzwh7@cdc.gov